| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |